Ignite Creation Date:
2024-05-06 @ 1:30 AM
Last Modification Date:
2024-10-26 @ 11:05 AM
Study NCT ID:
NCT01825317
Status:
COMPLETED
Last Update Posted:
2014-04-21
First Post:
2013-04-02
Brief Title:
Effect of NeuroAD on Alzheimer Patients
Sponsor:
Neuronix Ltd
Organization:
Neuronix Ltd
Study Overview
Official Title:
Effect of NeuroAD Combined TMS Stimulation and Cognitive Training on the Cognitive Function of Mild to Moderate Alzheimer Patients
Status:
COMPLETED
Status Verified Date:
2014-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Non-invasive stimulation of the brain using magnetic and cognitive stimulation by computer for the treatment of Alzheimer patients
Detailed Description:
Synchronized TMS and cognitive training for the treatment of mild to moderate Alzheimers patients Treatment is delivered 5 days a week for 6 weeks visit is about an hour long
Evaluation is by neuropsychological evaluation at 6 weeks
Evaluation is by neuropsychological evaluation at 6 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None